5 Key Takeaways

• 1

  Advancements in glaucoma care include new therapies and delivery methods that enhance patient outcomes and adherence.

• 2

  Selective laser trabeculoplasty (SLT) is a cost-effective first-line treatment that may reduce the need for surgical interventions.

• 3

  QLS-111, an ATP-sensitive potassium channel opener, shows promise in lowering intraocular pressure when added to existing therapies.

• 4

  Sustained-release implants and transdermal creams are emerging as innovative delivery methods to improve patient compliance.

• 5

  Understanding glaucoma's pathophysiology is crucial for developing disease-interrupting treatments, which remain a future goal.